Skip Navigation

Profile

Victor Enrique Ortega, M.D.Wake Forest Baptist Health

Doctor Rating

4.6 out of 5

59 Ratings
8 Comments
 

Victor Enrique Ortega, M.D.

Assistant Professor,

Clinical Interests

Chronic Obstructive Pulmonary Disease (COPD), Airway Disease, Asthma

Contact Information

Department: 336-716-4649

Insurance Accepted »

Additional Languages

Spanish

Education & Training

  • B.S., Tulane University, 1998
  • M.D., Ponce School of Medicine-Puerto Rico, 2002
  • Internship, Internal Medicine, Cleveland Clinic Foundation, 2003
  • Residency, Internal Medicine, Cleveland Clinic Foundation, 2005
  • Fellowship, WFU School of Medicine, 2007
  • Fellowship, Pulmonary Disease, WFU School of Medicine, 2010

Board Certifications

  • American Board of Internal Medicine, Critical Care Medicine
  • American Board of Internal Medicine, Pulmonary Disease

NPI Number

  • 1821266453
Victor Enrique Ortega, M.D.

Doctor Rating

4.6 out of 5

59 Ratings
8 Comments
 

Victor Enrique Ortega, M.D.

Assistant Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine
Maya Angelou Center for Health Equity

Research Interests

Asthma; Adrenergic beta-Agonists; Receptors, Adrenergic, beta-2; Pharmacogenetics; Polymorphism, Single Nucleotide
More »

Contact Information

Academic: 336-716-4649 | Department: 336-716-4649

Recent Publications

On a collision course: the electronic medical record and genetic studies of asthma [editorial]. Ortega VE, Torgerson DG.. Am J Respir Crit Care Med. 2017;195(4):412-414.

Understanding at-risk subgroups for lung function impairment in life-long nonsmokers with alpha1-antitrypsin deficiency [editorial]. Ortega VE, Pecchiari M.. Eur Respir J. 2017;49(3):1700114.

Income is an independent risk factor for worse asthma outcomes [abstract]. Cardet JC, King TS, Louisias M, Castro M, Codispoti CD, Dunn R, Giles BL, Holguin F, Lima J, Long D, Lugogo N, Nyenhuis SM, Ortega VE, Ramratnam S, Wechsler ME, Israel E, Phipatanakul W.. J Allergy Clin Immunol. 2016;137(2 Suppl):AB9.

The advent of high-throughput sequencing studies of chronic obstructive pulmonary disease [editorial]. Ortega VE, Celedon JC.. Am J Respir Crit Care Med. 2016;193(12):1323-1324.

A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome. Mathias RA, Taub MA, Gignoux CR, Fu W, Musharoff S, O'Connor TD, Vergara C, Torgerson DG, Pino-Yanes M, Shringarpure SS, Huang L, Rafaels N, Boorgula MP, Johnston HR, Ortega VE, Levin AM, Song W, Torres R, Padhukasahasram B, Eng C,.. Nat Commun. 2016;7():12522.

Chronic bronchitis and airway thickening are associated with higher levels of growth differentiation factor-15 (gdf-15) in smokers without airflow obstruction: an analysis of the Spiromics Cohort [abstract]. Martinez CH, Freeman CM, Nelson JD, Anderson WH, Bowler RP, Cooper CB, Couper DJ, Han MK, Martinez FJ, O'Neal WK, Ortega VE, Paine R III, Woodrull PG, Curtis JL.. Am J Respir Crit Care Med. 2016;193():A3510.

Blood eosinophils poorly correlate with sputum eosinophils, and have few associations with spirometry, clinical and quantitated computed tomography measures compared to sputum eosinophils in the spiromics cohort [abstract]. Hastie AT, Alexis NE, Doerschuk C, Hansel NN, Christenson S, Putcha N, Ortega VE, Peters SP, Barr RG, Couper DJ, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Han MK, Meyers DA, Curtis JL, Bleecker ER.. Am J Respir Crit Care Med. 2016;193():A6168.

Predictors of inhaled corticosteroid reduction failure in adult asthmatics [abstract]. Cardet JC, King TS, Bacharier LB, Carr TF, Chinchilli VM, Codispoti CD, Dunn RM, Holguin F, Nelson KF, Ortega VE, Peters M, Ramratnam S, Wechsler ME, Israel E.. Am J Respir Crit Care Med. 2016;193():A1310.

Genetic ancestry is associated with baseline lung function, CT-scan emphysema, and COPD risk in African Americans and Hispanics from spiromics [abstract]. Ortega VE, Hoffman EA, Ampleford EJ, Hawkins GA, Barr RG, Couper DJ, Han MK, Kanner R, Kleerup E, Martinez FJ, Rennard SI, Woodruff PG, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2016;193():A6164.

Cluster analysis of chronic obstructive pulmonary disease (COPD) related phenotypes in the subpopulations and intermediate outcome measures in COPD Study (spiromics) [abstract]. Li X, Han MK, Ortega VA, Dransfield MT, Li H, Barr RG, Couper DJ, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2016;193():A3509.

Genome-wide association identifies Rs28929474 (glu342lys) in serpina1 associated with post-bronchodilator Fev1/FVC and percent predicted Fev1 in spiromics [abstract]. Li X, Ortega VE, Ampleford EJ, Barr RG, Couper DJ, Han MK, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Hawkins GA, Bleecker ER, Meyers DA.. Am J Respir Crit Care Med. 2016;193():A4431.

Phenotypic/genetic characteristics of COPD, asthma, and asthma-COPD overlap syndrome (acos) in spiromics and sarp [abstract]. Li X, Ortega VE, Nadia H, Christenson S, Moore WC, Li H, Barr RG, Couper DJ, Hoffman EA, Han MK, Kanner R, Kleerup E, Martinez FJ, Hawkins GA, Woodruff PG, Bleecker ER, Meyers DA.. Am J Respir Crit Care Med. 2016;193():A6237.

Rare serpina1 variants in the multi-ethnic spiromics population [abstract]. Ortega VE, Li X, O'Neal WK, Pennington EJ, Barr RG, Couper DJ, Han MK, Kanner R, Kleerup E, Martinez FJ, Peters SP Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2016;193():A4433.

Asthma pharmacogenetics and the development of genetic profiles for personalized medicine. Ortega VE, Meyers DA, Bleecker ER.. Pharmgenomics Pers Med. 2015;8():9-22.

Predictive genetic profiles for beta-agonist therapy in asthma. A future under construction [editorial]. Ortega VE.. Am J Respir Crit Care Med. 2015;191(5):494-496.

The effect of ancestry and genetic variation on lung function predictions: what is 'normal' lung function in diverse human populations?. Ortega VE, Kumar R.. Curr Allergy Asthma Rep. 2015;15(4):16.

African ancestry is associated with disease misclassification, airflow obstruction, and CT scan emphysema in African Americans from spiromics [abstract]. Ortega VE, Ampleford EJ, Hawkins G, Barr RG, Couper D, Han MK, Hoffman EA, Kanner RE, Kleerup EC, Martinez FJ, Rennard SI, Woodruff PG, Bleecker ER, Meyers DA.. Am J Respir Crit Care Med. 2015;191():A2297.

African ancestry is associated with lung function, healthcare utilization, and airways inflammation in African Americans with asthma [abstract]. Ortega VE, Moore WC, Zein J, Hastie AT, Ampleford E, Peters SP, Busse WW, Castro M, Erzurum SC, Israel E, Wenzel SE, Hawkins G, Bleecker ER, Meyers DA.. Am J Respir Crit Care Med. 2015;191():A1061.

Rare serpina1 variants are associated with lung function and health care utilization in a multi-ethnic population from the Severe Asthma Research Program (sarp) [abstract]. Pasha S, Orgega VE, Ampleford EJ, Bamshad MJ, Barnes KC, Busse WW, Castro M, Erzurum SC, Israel E, Mathias RA, Nickerson D, Wenzel SE, Hawkins G, Bleecker ER, Meyers DA.. Am J Respir Crit Care Med. 2015;191():A6057.

The value of whole genome sequencing in identifying genetic determinants of asthma in populations of African ancestry [abstract]. Mathias RA, Johnston HR, Torgerson D, Levin AM, Lange LA, Ortega VE, Hu Y, Caraballo L, Foreman MG, Hartert T, Herrera-Paz E, Knight-Madden JM, Kumar R, Mayorga A, Olopade C, Ware, LB, Marrugo J, Oliveira RR, Yazdanbakhsh M, Wilson JG,.. Am J Respir Crit Care Med. 2015;191():A1063.

Evaluation of genetic variants in Il6 and Il6r in the Nhlbi subpopulations and intermediate outcome measures in COPD study (spiromics) [abstract]. Hawkins GA, Ampleford EJ, Ortega VE, Li X, Peters SP, Barr RG, Couper D, Han MK, Kanner R, Kleerup EC, Martinez FJ, Rennard SI, Woodruff PG, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2015;191():A4693.

Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. Ortega VE, Meyers DA.. J Allergy Clin Immunol. 2014;133(1):16-26.

Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting beta agonist treatment in a multiethnic asthma population: a genetic study. Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D,Erzurum SC, Israel E, Montealegre F, Wezel SE, Peters SP, Meyers DA, Bleecker ER.. Lancet Respir Med. 2014;2(3):204-213.

The beta2-adrenergic receptor gene: its influence on inhaled beta agonist responsiveness. Ortega VE, Bleecker ER. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ, Young PM, Traini D, eds. Respiratory drug delivery. RDD online;2014: 61-74.

African ancestry is associated with lower baseline lung function, misclassification of disease severity, and healthcare utilization in African Americans with severe asthma [abstract]. Ortega VE, Moore WC, Hawkins G, Ampleford EJ, Busse WW, Castro M, Erzurum SC, Israel E, Wenzel SE, Peters SP, Bleecker ER, Meyers DA.. Am J Respir Crit Care Med. 2014;189():A6366.

Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management. Ortega VE.. Clin Genet. 2014;86(1):12-20.

Implications of population structure and ancestry on asthma genetic studies. Ortega VE, Meyers DA.. Curr Opin Allergy Clin Immunol. 2014;14(5):381-389.

Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, Peters SP, Meyers DA, Bleecker ER.. J Allergy Clin Immunol. 2013;132(1):72-80.

Asthma pharmacogenetics: responding to the call for a personalized approach. Ortega VE, Wechsler ME.. Curr Opin Allergy Clin Immunol. 2013;13(4):399-409.

Pharmacogenetics and the development of personalized approaches for combination therapy in asthma. Miller SM, Ortega VE.. Curr Allergy Asthma Rep. 2013;13(5):443-452.

Exome sequencing of beta2-adrenergic receptor pathway genes reveals rare variants associated with asthma severity In African Americans [abstract]. Ortega VE, Slager RE, Hawkins G, Moore WC, Busse WW, Erzurum SC, Wenzel SE, Barnes KC, Mathias RA, Bamshad MJ, Nickerson D, Peters SP, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2013;187():A2129.

Whole exome sequencing analysis reveals rare genetic variants associated with response to beta2- adrenergic receptor agonists in African American asthmatics [abstract]. Ortega VE, Miller SM, Slager RE, Hawkins G, Moore WC, Busse WW, Erzurum SC, Wenzel SE, Barnes KC, Mathias RA, Bamshad MJ, Nickerson D, Peters SP, Bleecker ER, Meyers DA.. Am J Respir Crit Care Med. 2013;187(Meeting Abstracts):A2122.

Characterization of rare variants in the Adam33 gene in asthma cases from two ethnic groups [abstract]. Ortega VE, Hawkins G, Moore WC, Sadeghnejad A, Busse WW, Erzurum SC, Wenzel SE, Peters SP, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2012;185(Meeting Abstracts):A5609.

Effects of rare beta2-adrenergic receptor gene variants and long-acting beta agonists on healthcare utilization and corticosteroid use in two multi-ethnic asthma populations [abstract]. Ortega VE, Hawkins G, Hastie AT, Moore WC, Sadeghnejad A, Busse WW, Erzurum SC, Wenzel SE, Peters SP, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2012;185(Meeting Abstracts):A2514.

The pharmacogenetics of asthma and the road to personlized medicine. Ortega VE, Bleecker ER.. Pulmao RJ. 2012;21(2):41-52.

The safety of long-acting beta-agonists and the development of combination therapies for asthma and COPD. Ortega VE, Bleecker ER. In: Lotvall J, Busse WW, eds. Advances in combination therapy for asthma and COPD. Chichester, West Sussex: John Wiley & Sons;2012: 102-134.

Rare beta2-adrenergic receptor gene polymorphisms in asthma cases and controls from the Severe Asthma Research Program [abstract]. Ortega VE, Hastie A, Sadeghnejad A, Moore W, Hawkins GA, Peters SP, Busse WW, Calhoun WJ, Meyers DA, Bleecker ER, et al.. Am J Respir Crit Care Med. 2011;183(Meeting Abstracts):A1357.

Methylation-specific sequencing of the beta2 adrenergic receptor gene in asthma cases and controls [abstract]. Ortega VE, Meyers DA, Bleecker ER, Hawkins GA.. Am J Respir Crit Care Med. 2009;179(Meeting Abstracts):A5433.

Sequencing of the beta2 adrenergic receptor gene and association with asthma susceptibility in a US Hispanic population from New Mexico [abstract]. Ortega VE, Hawkins GA, Harkins M, Meyers DA, Bleecker ER.. Am J Respir Crit Care Med. 2008;177(Meeting Abstracts):A334.

Sequencing of the beta2 adrenergic receptor gene in Puerto Ricans with asthma [abstract]. Ortega VE, Montealegre F, Chardon D, Meyers DA, Diallo AF, Ampleford EJ, Hawkins GA, Bleecker ER.. Am J Respir Crit Care Med. 2007;175(Abstr Issue):A461.

A roadmap to functional genomics. Penn RB, Ortega VE, Bleecker ER.. Physiol Genomics. 2007;30(1):82-88.

Pharmacogenetics of the beta2-adrenergic receptor gene. Ortega VE, Hawkins GA, Peters SP, Bleecker ER.. Immunol Allergy Clin North Am. 2007;27(4):665-684.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine

Clinical Interests

Chronic Obstructive Pulmonary Disease (COPD), Airway Disease, Asthma
Victor Enrique Ortega, M.D.

Victor Enrique Ortega, M.D.

Assistant Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine
Maya Angelou Center for Health Equity

Doctor Rating

4.6 out of 5

Victor Enrique Ortega, M.D.59 Ratings
8 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
3.6



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

4/3/2017

Keep up the good work!

3/28/2017

*Dr. Ortega is a great advocate for my personal care.

12/20/2016

*Dr. Ortega is such a kind, knowledgeable and caring physician. He always has my health as his concern when I see him. He is awesome!

10/26/2016

Good.

9/15/2016

Good care from *Doctor Ortega and nurses.

8/23/2016

I would recommend this provider if his clinic ran smoother and if his available was more than one day per week. His limited schedule makes it difficult to schedule any appointment (urgent, follow-up, or check-up). His ability to be present in the moment and the care he shows mostly makes up for the frustration caused by clinic issues, at least for me.

8/16/2016

Once again, Dr. Ortega is always patient and courteous. I have poor hearing and he frequently has to repeat himself for me. He always goes over my newest test results (usually done an hour before I see him) and informs me of any changes.

5/31/2016

I recommend *Dr. Ortega to everyone w/pulmonary issues.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Five Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is RenewedMagnet Hospital Recognition2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.